HOLLAND & KNIGHT LLP for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug Pricing; Intellectual property; Drug pricing; Intellectual property; S.1895, Lower Health Care Costs Act; S.1416, Affordable Prescriptions for Patients Act of 2019.
Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK | — |
| MICHAEL WERNER | — |
Pharmacy PHA
Drug pricing; Intellectual property; S.1895, Lower Health Care Costs Act; S.1416, Affordable Prescriptions for Patients Act of 2019.
Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK | — |
| MICHAEL WERNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.